Literature DB >> 11159750

Effect of dietary galacto-oligosaccharides on azoxymethane-induced aberrant crypt foci and colorectal cancer in Fischer 344 rats.

M V Wijnands1, H C Schoterman, J B Bruijntjes, V M Hollanders, R A Woutersen.   

Abstract

The aim of the present study was to investigate the effects of galacto-oligosaccharides (GOS, Elix'or) on the development of aberrant crypt foci (ACF) and colorectal tumours in rats treated with azoxymethane (AOM). Two groups of 102 male Fischer 344 rats were injected twice with AOM to induce colorectal tumours, and fed diets containing either a low [5% (w/w); LGOS] or a high [20% (w/w); HGOS] concentration of GOS. Four weeks after the last AOM injection, 18 animals from each group were killed and their colon was removed for scoring ACF. Half of the animals in the LGOS group were switched to an HGOS diet (L/HGOS) and half of those in the HGOS group to an LGOS diet (H/LGOS). Six weeks after the change in diet, nine animals per group were killed for scoring ACF. Ten months after the start of the study the remaining animals were killed for scoring colorectal tumours. The aberrant crypt multiplicity scored after 13 weeks and the colorectal tumour incidence in rats fed an HGOS diet were significantly lower than those in rats fed an LGOS diet. However, the induction of ACF by AOM, the proliferation rate and apoptotic index of the adenomas, and the size and multiplicity of colorectal tumours were not influenced by the amount of GOS in the diet. The aberrant crypt multiplicity, scored after 13 weeks, was predictive for the tumour outcome at the end of the study. It was concluded that an HGOS diet has a protective effect against the development of colorectal tumours in rats and that this protective effect is exerted during the promotion phase rather than the initiation phase of carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159750     DOI: 10.1093/carcin/22.1.127

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Galacto-oligosaccharides and Colorectal Cancer: Feeding our Intestinal Probiome.

Authors:  Jose M Bruno-Barcena; M Andrea Azcarate-Peril
Journal:  J Funct Foods       Date:  2015-01       Impact factor: 4.451

3.  Fructooligosaccharide intake promotes epigenetic changes in the intestinal mucosa in growing and ageing rats.

Authors:  Glaucia Carielo Lima; Vivian Cristine Correa Vieira; Cinthia Baú Betim Cazarin; Rafaela da Rosa Ribeiro; Stanislau Bogusz Junior; Cibele Lima de Albuquerque; Ramon Oliveira Vidal; Claudia Cardoso Netto; Áureo Tatsumi Yamada; Fabio Augusto; Mário Roberto Maróstica Junior
Journal:  Eur J Nutr       Date:  2017-03-21       Impact factor: 5.614

4.  Arabinoxylan-oligosaccharides (AXOS) reduce preneoplastic lesions in the colon of rats treated with 1,2-dimethylhydrazine (DMH).

Authors:  Angelo Pietro Femia; Maddalena Salvadori; Willem F Broekaert; Isabelle E J A François; Jan A Delcour; Christophe M Courtin; Giovanna Caderni
Journal:  Eur J Nutr       Date:  2009-08-27       Impact factor: 5.614

Review 5.  Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer.

Authors:  Maya Raman; Padma Ambalam; Kanthi Kiran Kondepudi; Sheetal Pithva; Charmy Kothari; Arti T Patel; Ravi Kiran Purama; J M Dave; B R M Vyas
Journal:  Gut Microbes       Date:  2013-03-19

Review 6.  The Life-Long Role of Nutrition on the Gut Microbiome and Gastrointestinal Disease.

Authors:  Joann Romano-Keeler; Jilei Zhang; Jun Sun
Journal:  Gastroenterol Clin North Am       Date:  2021-01-05       Impact factor: 3.806

7.  Novel Combination of Prebiotics Galacto-Oligosaccharides and Inulin-Inhibited Aberrant Crypt Foci Formation and Biomarkers of Colon Cancer in Wistar Rats.

Authors:  Tahir Rasool Qamar; Fatima Syed; Muhammad Nasir; Habib Rehman; Muhammad Nauman Zahid; Rui Hai Liu; Sanaullah Iqbal
Journal:  Nutrients       Date:  2016-08-01       Impact factor: 5.717

8.  Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model.

Authors:  João C Fernandes; José Sereno; Patricia Garrido; Belmiro Parada; Maria F X Cunha; Flávio Reis; Manuela E Pintado; Alice Santos-Silva
Journal:  Mar Drugs       Date:  2012-12       Impact factor: 5.118

9.  Feeding of soy protein isolate to rats during pregnancy and lactation suppresses formation of aberrant crypt foci in their progeny's colons: interaction of diet with fetal alcohol exposure.

Authors:  Amanda L Linz; Rijin Xiao; James G Parker; Pippa M Simpson; Thomas M Badger; Frank A Simmen
Journal:  J Carcinog       Date:  2004-10-15

10.  Impact of Novel Prebiotic Galacto-Oligosaccharides on Various Biomarkers of Colorectal Cancer in Wister Rats.

Authors:  Tahir Rasool Qamar; Sanaullah Iqbal; Fatima Syed; Muhammad Nasir; Habib Rehman; Muhammad Aamir Iqbal; Rui Hai Liu
Journal:  Int J Mol Sci       Date:  2017-08-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.